ClinicalTrials.gg
Enrolling by invitationNCT06077513Updated Oct 1, 2026

Ti-Mesh Frame Comparison for Alveolar Bone Augmentation

An interventional study of CAD-CAM designed and preprinted Ti-Mesh frame and Conventional chairside fabrication of Ti-Mesh frame in Tooth Loss, sponsored by Boston University. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-10-01.

Sponsored by Boston University · Not applicable, Interventional, and Treatment

Updated Oct 1, 2026Primary completion movedStudy completion movedGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

This research compares a chairside Titanium Mesh frame fabrication used during bone grafting procedures with the use of a computer-aided design/computer-assisted manufacture (CAD-CAM) Titanium Mesh frame. In addition, a novel method of measuring soft tissue thickness will be tested using an Optical scanner at various times during the sequence of surgeries.

The device used for shaping is a very thin, perforated titanium metal sheet with numerous small perforations (referred to as Micromesh). The construction of this device is usually accomplished chairside at the time of the surgery with custom cutting and shaping done using cues from the geometry of the surgical defect. An alternative approach will be tested where the mesh is pre-designed using digital information provided by a special xray and an optical scan device which takes a digital impression of the tooth and soft tissue surface. A digitally designed frame can then be printed using CAD-CAM software prior to surgery. This should reduce surgical time.

A randomized control trial of 30 patients needing 3-D bone augmentation will be conducted comparing chairside fabrication of Ti-MESH or TEST- CAD-CAM designed and preprinted Ti-MESH to investigate these objectives:

  1. Compare the operative times required for placement and removal of two different Ti-MESH frame fabrications
  2. Compare post-op wound healing -Ti MESH exposure rates, bone production (volume, contour, and quality) and soft tissue thickness changes during the 1-year study period.
02

Conditions studied

  • Tooth Loss

Browse trials for

Keywords

  • Conventional Ti-Mesh frame
  • CAD-CAM printed ti-Mesh frame
  • Dental implants
  • 3-D Alveolar Bone Augmentation
  • Surgery time
  • Post op mesh exposure
  • Post op bone added
03

In context

Tooth Loss

165 studies on the registry are indexed under Tooth Loss; 44 are open to participants now.

This study's planned enrollment of 30 is close to the median of 30 across 120 interventional studies indexed under Tooth Loss.

Browse Tooth Loss studies →

Lead sponsor

Boston University is the lead sponsor of 270 studies on the registry; 36 are open to participants now.

Of its 31 completed or terminated interventional studies of FDA-regulated products, 24 (77%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Partially edentulous
  • Adult dental patients that require moderate 3-D bone augmentation for dental implant site improvement

Exclusion criteria

Exclusion Criteria:

  • Poor oral hygiene indices for microbial plaque (PI) and gingival inflammation (GI)
  • Patients who have been on Chemotherapy or Radiation therapy within last 5 years.
  • Patients under active treatment with following medications: Bisphosphonates, Gabapentin, , Methotrexate, or Estrogen supplements.
  • Subjects under the direct supervision of the PI
  • Smoking more than 10 cigarettes per day
  • Uncontrolled diabetes or other metabolic disorders
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    CAD-CAM Ti-Mesh frame

    Participants randomized into this arm will have their tooth loss treated with CAD-CAM designed and preprinted Ti-MESH during surgery.

    Procedure: CAD-CAM designed and preprinted Ti-Mesh frame

  • Active comparator
    Conventional Ti-Mesh frame

    Participants randomized into this arm will have their tooth loss treated with conventional chairside fabrication of Ti-MESH during surgery.

    Procedure: Conventional chairside fabrication of Ti-Mesh frame

Interventions

  • ProcedureCAD-CAM designed and preprinted Ti-Mesh frame

    CAD-CAM technology which is the process of designing and manufacturing a custom-made dental device, or a patient-specific dental device from an industrialized product, with the aid of a computer.will be used to plan and preprint a 3-D Ti-Mesh frame prior to the surgery.

  • ProcedureConventional chairside fabrication of Ti-Mesh frame

    A three-dimensional frame or cage of Ti-Mesh or Ti-reinforced d-polytetrafluoroethylene (PTFE) will be fashioned during the surgery to contain, shape and stabilize the bone graft materials (the internal scaffold). This 3-D frame will be custom fabricated from a perforated Ti Mesh sheet material at the time of surgery which takes considerable time and skill.

06

What researchers measure

Primary outcomes

  1. Bone contour accuracy

    Bone contour accuracy will be derived by merger of the post op Cone beam computed tomography (CBCT) DICOM file with the CBCT-1/CEREC-1/Virtual Implant file produced at the planning stage. Accuracy of fit will be calculated for volume and linear measures (4 sides of each implant-MDBL) horizontal and vertical from the implant restorative platform.

    Time frame: 5 months post op

  2. Total surgical time

    Total surgical time is defined as from incision time to completion of sutures and will be measured in minutes.

    Time frame: 2 hours

  3. Surgical exposure time for recipient site

    Surgical exposure time will be measured for recipient site in minutes

    Time frame: 5 minutes

Secondary outcomes

  1. Ti-Mesh exposure incidence

    Number of exposures

    Time frame: 1 week, 2 weeks, 4weeks, 8 weeks, 12 weeks, 16 weeks, 20 weeks, 24 weeks

  2. Ti-Mesh exposure size

    Ti-Mesh exposure size will be measured in millimeters

    Time frame: 1 week, 2 weeks, 4weeks, 8 weeks, 12 weeks, 16 weeks, 20 weeks, 24 weeks

  3. Ti-Mesh exposure location

    Ti-Mesh exposure location will be documented within mucosa, gingiva, or at the incision line

    Time frame: 1 week, 2 weeks, 4weeks, 8 weeks, 12 weeks, 16 weeks, 20 weeks, 24 weeks

  4. Percentage of Vital bone

    Percentage of vital bone will be measured in histologic sections of bone core taken at time of implant surgery.

    Time frame: 6 months

07

Study locations

1 site
  • BU Goldman School of Dental Medicine
    Boston, Massachusetts 02118, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Primary completion
Sep 2026→Sep 2027
Oct 1, 2026
Study completion
Dec 2026→Dec 2027
Oct 1, 2026
Show all 1 update
  1. Oct 1, 2026
    Primary completion Sep 2026→Sep 2027
    Study completion Dec 2026→Dec 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06077513
Lead sponsor
Boston University
Responsible party
Sponsor
First posted
Oct 11, 2023
Start date
Jan 25, 2024
Primary completion
Sep 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Oct 1, 2026

Study contacts

Serge Dibart, DMD
principal investigator · BU Goldman School of Dental Medicine, Oral Biology/Periodontics
Albert M Price, DMD
study director · BU Goldman School of Dental Medicine, Oral Biology/Periodontics

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion